HANNAH JOSEPH HOSPITAL SHARE PRICE

Hannah Joseph Hospital Limited is one of the first centres in Asia to adopt DTI Fibertracking 3.0, a revolutionary navigation tool for brain tumour surgeries. To provide comprehensive range of neurosurgery and neurology services, Mosesjoseph Arunkumar established a hospital in the name of `Hannah Joseph Hospital` as a sole proprietorship in Madurai town of Tamil Nadu, in 2008. On September 9, 2008, the hospital became a member of Nursing Homes and Hospital Board, Indian Medical Association Tamil Nadu State. Later, Hannah Joseph Hospital Limited was incorporated as a private limited as "Hannah Joseph Hospital Private Limited" at Tamil Nadu as a private limited company , dated October 24, 2011, issued by the Registrar of Companies, Tamil Nadu. Subsequently, Company changed its status to a public limited company and the name of the Company was changed to `Hannah Joseph Hospital Limited` vide fresh certificate of incorporation dated July 29, 2022. Company is being promoted by Mosesjoseph Arunkumar (Neurosurgeon at Hospital), and Fenn Kavitha Fenn Arunkumar (Consultant Psychiatrist at Hospital). Recognizing the demand for increased bed capacity and lack of space, the hospital was relocated in year 2020. This expansion mark a notable development for the Company, signifying sustained growth and progress in the healthcare services. Hannah Jospeh Hospital Limited, a multi-speciality healthcare provider, strategically located in Madurai, operating in a two acres campus, centrally air-conditioned hospital with central water heating system with a combined bed capacity of 150 beds. Company is rendering medical services to public through Hannah Joseph Hospital, which is a renowned center of excellence for Neurology, Neurosurgery and Psychiatry treatment. The medical facility encompasses full-fledged department of neuroradiology and has added the department of cardiac sciences with a Cath lab and cardiac operation theatres. The Company now performs complex coronary angioplasties and open-heart Surgeries. Currently, their primary focus is Neurology, Cardiology, Physchiarty and Trauma healthcare where the Hospital has a understanding of global nuances, customer culture and the mindset of medical professionals and where there is a significant need for quality and affordable healthcare services. In 2023, rare case of the Temporomandibular Joint Replacement Surgery was done by the Department of Oral Maxillofacial Surgery. In 2024, Brain lab Fiber tracking Navigation 3.0 version for removing brain tumours has been launched. Company raised Rs 42 Crore by issuing 60,00,000 equity shares of Rs 10 each through IPO on January 28, 2026. The Company is proposing to set up he Proposed Radiation Oncology Centre adjacent to the current hospital campus in 2026.

Hannah Joseph Hospital share price as on 18 Feb 2026 is Rs. 66.9. Over the past 6 months, the Hannah Joseph Hospital share price has increased by 0% and in the last one year, it has decreased by 1.98%. The 52-week low for Hannah Joseph Hospital share price was Rs. 61.75 and 52-week high was Rs. 71.66.

Hannah Joseph Hospital Limited is one of the first centres in Asia to adopt DTI Fibertracking 3.0, a revolutionary navigation tool for brain tumour surgeries. To provide comprehensive range of neurosurgery and neurology services, Mosesjoseph Arunkumar established a hospital in the name of `Hannah Joseph Hospital` as a sole proprietorship in Madurai town of Tamil Nadu, in 2008. On September 9, 2008, the hospital became a member of Nursing Homes and Hospital Board, Indian Medical Association Tamil Nadu State. Later, Hannah Joseph Hospital Limited was incorporated as a private limited as "Hannah Joseph Hospital Private Limited" at Tamil Nadu as a private limited company , dated October 24, 2011, issued by the Registrar of Companies, Tamil Nadu. Subsequently, Company changed its status to a public limited company and the name of the Company was changed to `Hannah Joseph Hospital Limited` vide fresh certificate of incorporation dated July 29, 2022. Company is being promoted by Mosesjoseph Arunkumar (Neurosurgeon at Hospital), and Fenn Kavitha Fenn Arunkumar (Consultant Psychiatrist at Hospital). Recognizing the demand for increased bed capacity and lack of space, the hospital was relocated in year 2020. This expansion mark a notable development for the Company, signifying sustained growth and progress in the healthcare services. Hannah Jospeh Hospital Limited, a multi-speciality healthcare provider, strategically located in Madurai, operating in a two acres campus, centrally air-conditioned hospital with central water heating system with a combined bed capacity of 150 beds. Company is rendering medical services to public through Hannah Joseph Hospital, which is a renowned center of excellence for Neurology, Neurosurgery and Psychiatry treatment. The medical facility encompasses full-fledged department of neuroradiology and has added the department of cardiac sciences with a Cath lab and cardiac operation theatres. The Company now performs complex coronary angioplasties and open-heart Surgeries. Currently, their primary focus is Neurology, Cardiology, Physchiarty and Trauma healthcare where the Hospital has a understanding of global nuances, customer culture and the mindset of medical professionals and where there is a significant need for quality and affordable healthcare services. In 2023, rare case of the Temporomandibular Joint Replacement Surgery was done by the Department of Oral Maxillofacial Surgery. In 2024, Brain lab Fiber tracking Navigation 3.0 version for removing brain tumours has been launched. Company raised Rs 42 Crore by issuing 60,00,000 equity shares of Rs 10 each through IPO on January 28, 2026. The Company is proposing to set up he Proposed Radiation Oncology Centre adjacent to the current hospital campus in 2026.

Hannah Joseph Hospital share price as on 18 Feb 2026 is Rs. 66.9. Over the past 6 months, the Hannah Joseph Hospital share price has increased by 0% and in the last one year, it has decreased by 1.98%. The 52-week low for Hannah Joseph Hospital share price was Rs. 61.75 and 52-week high was Rs. 71.66.